Initial Therapeutics Raises $75M in Series A Funding - FinSMEs

Initial Therapeutics Raises $75M In Series A Funding - FinSMEs

2 weeks from now

May 1, 2023  · Initial Therapeutics, a South San Francisco, CA-based biotechnology company, raised $75m in Series A funding. Apple Tree Partners created the company and made the …

finsmes.com

With $75 Million From Apple Tree Partners, Initial Therapeutics ...

2 weeks from now

Company’s novel approach seeks to halt serious diseases in initial stages NEW YORK and SOUTH SAN FRANCISCO, May 1, 2023 – Apple Tree Partners (ATP), a leader in life …

initialtx.com

Initial Launches With $75M And A New Idea For Targeting …

2 weeks from now

May 1, 2023  · A new biotechnology startup aims to treat cancer and other serious illnesses by stopping cells from making disease-causing proteins, and has raised $75 million from venture …

biopharmadive.com

Series A - Initial Therapeutics - 2023-05-01 - Crunchbase Funding …

2 weeks from now

May 1, 2023  · Initial Therapeutics raised $75000000 on 2023-05-01 in Series A

crunchbase.com

Initial Therapeutics Raises $75 Million Series A Funding

2 weeks from now

May 9, 2023  · The company is leveraging the latest advances in biotechnology, including genomics, proteomics, and computational biology, to discover new drug targets and develop …

investclub.sv

Venture Capital News: Initial Therapeutics Raises $75M Series A …

2 weeks from now

Initial Therapeutics was started With $75M from Apple Tree Partners, to Create a New Kind of Drug Designed to Stop the Formation of Difficult-to-Drug Protein Targets. Initial Therapeutics, …

vcnewsdaily.com

Initial Therapeutics Raises $75M Series A Funding - Vcnewsdaily.com

2 weeks from now

May 1, 2023  · Initial Therapeutics was started With $75M from Apple Tree Partners, to Create a New Kind of Drug Designed to Stop the Formation of Difficult-to-Drug Protein Targets.

vcnewsdaily.com

Initial Therapeutics: Initial Therapeutics: $75 Million Closed ... - Owler

2 weeks from now

Apple Tree Partners (ATP) - a leader in life sciences venture capital - announced the launch of Initial Therapeutics, a biotechnology company created to make medicines that block …

owler.com

Founder Lodge | Initial Therapeutics Raises $75,000,000 At Series A …

2 weeks from now

May 2, 2023  · Initial Therapeutics start up United States - South San Francisco, California 02/05/2023 Series A $75,000,000 Initial Therapeutics is discovering and developing a new …

founderlodge.com

With $75 Million From Apple Tree Partners, Initial Therapeutics ...

2 weeks from now

May 1, 2023  · Initial was created by ATP with $75 million in Series A funding and co-founders Jamie H.D. Cate, Ph.D., Professor of Chemistry, Biochemistry, Biophysics, and Structural …

biospace.com

Initial Therapeutics Raises $75M To Develop Therapies That Stop ...

2 weeks from now

May 3, 2023  · Initial Therapeutics has raised a $75M Series A funding round to develop therapies that stop diseases in their early stages. Apple Tree Partners led the investment.

milled.com

Initial Therapeutics 5/1/2023 Capital Raise - Gaebler.com Venture ...

2 weeks from now

May 1, 2023  · Initial Therapeutics secured a $75 million Series A venture capital round on 5/1/2023. Investors included Apple Tree Partners.

gaebler.com

Initial Therapeutics Stock Price, Funding, Valuation, Revenue ...

2 weeks from now

Initial Therapeutics has raised $75M over 1 rounds. Initial Therapeutics's latest funding round was a Series A for $75M on May 1, 2023.

cbinsights.com

Initial Therapeutics: $75 Million Closed For Launching A New Drug …

2 weeks from now

May 8, 2023  · Apple Tree Partners (ATP) - a leader in life sciences venture capital - announced the launch of Initial Therapeutics, a biotechnology company created to make medicines that …

pulse2.com

Initial Therapeutics - Overview, News & Similar Companies

2 weeks from now

Apr 30, 2023  · Initial Therapeutics, a South San Francisco, CA-based biotechnology company, raised $75m in Series A funding. Apple Tree Partners created the company and made the …

zoominfo.com

Coeptis Adds $5.7M To Series A, Raises Total To $10M

2 weeks from now

8 hours ago  · Wexford-based biopharmaceutical company Coeptis announced that it had closed on a $5.7 million addition to its preferred Series A, bringing the total funding round to $10 million.

bizjournals.com

Atalanta Therapeutics Raises $75M In Series B Funding

2 weeks from now

Jan 28, 2025  · Atalanta Therapeutics, a Boston, MA-based company developing RNA interference (RNAi) to treat neurological diseases, raised $75M in Series B funding.

finsmes.com